- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 347
Business finance platform Compeon raises $2.8m
Tengelmann's corporate venturing subsidiary joined Dieter von Holtzbrinck-backed DvH Ventures and B-to-V to fund Compeon's series A round.
Feb 12, 2016Cobi pedals to $7m series A
Meinders & Elstermann was among the investors as Cobi, the creator of a connected bike control system, raised $7.1m to take its overall funding to $11.5m.
Feb 12, 2016Diffbot switches on with $10m
The web data collection company added Tencent to its investor base in a series A round that followed a June 2015 investment by Bloomberg.
Feb 12, 2016Federated Wireless connects to $22m series A
Allied Minds invests in its subsidiary Federated Wireless' $22m series A round to help it bring its phone spectrum management system to market.
Feb 12, 2016Hexadite secures $8m in series A round
Hewlett Packard Ventures was among the backers in a round that will be used to beef up the cybersecurity startup's R&D, sales and marketing.
Feb 11, 2016Latch unlocks $10.5m
The smart lock developer, a graduate of R/GA Accelerator, has now raised $16m in total after closing a series A round led by Lux Capital.
Feb 11, 2016Silk smooths out series A with $6m
Skincare brand Silk Therapeutics has secured $6m in a series A round featuring Lear Corporation and existing investor Kraft Group.
Feb 10, 2016EpiBiome executes $6m series A
EpiBiome, a past winner of Johnson & Johnson's JLabs QuickFire Challenge, has raised $6m in an Alexandria Real Estate Equities-backed round
Feb 10, 2016Crowdynews gets social for $7m series A
The social media curation platform has received additional funding from Inkef Capital to boost its Singapore Press Holdings-backed series A round to $7m.
Feb 10, 2016Yumanity to evolve with $45m
Biogen and Sanofi are among the investors in a series A round closed by Yumanity Therapeutics, which plans to now advance its neurological disease treatment platforms.
Feb 10, 2016About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


